Sohn Conference: AI and GLP-1 Redefine Investment

⚡

Key Takeaways

1Rahul Kishore presented Axon Enterprises at the Sohn conference, highlighting the impact of AI on its products.

2Kevin Salimian from Voxel Capital anticipates a 58% increase for Infineon Technologies due to the rise of AI.

3Zachary Datikash is betting against DaVita, expecting a decline in dialysis demand due to advancements in GLP-1.

💡Why it matters — These strategies illustrate how AI and medical innovations are redefining investment outlooks.

AI and New Trends at the Heart of the Sohn Conference

At the recent Sohn Conference, a must-attend event for investors, Rahul Kishore, a former Coatue executive, introduced his AI agent, Eve. This presentation left a lasting impression by highlighting the growing importance of artificial intelligence in the financial sector. Young hedge fund founders took advantage of this platform to unveil their innovative ideas, with a particular focus on current trends such as AI and GLP-1.

AI was a central topic at this conference, although intelligent agents have not yet taken over to make stock recommendations. Eve, Rahul Kishore's AI assistant, captivated the audience by expressing her need for better air conditioning in her data center, a humorous touch that introduced Kishore's presentation on Axon Enterprises.

Axon Enterprises: An AI-Focused Investment Opportunity

Rahul Kishore, who founded Epicenter Capital last year after eight years at Coatue, highlighted Axon Enterprises, a company specializing in the manufacture of tasers and body cameras for law enforcement. The interest in this company lies in its suite of AI-based tools, which are growing faster than its traditional products. Among these tools is transcription software capable of generating drafts of police reports from videos captured by body cameras.

Kishore predicts that Axon's stock value could double by the end of 2028, a prospect that captured attention during this conference dedicated to the "next wave" of the hedge fund industry.

The "Next Wave" of Fund Managers

For over a decade, the Sohn Conference has provided a platform for emerging managers to present their ideas to the financial industry's elite. This year, the presentations highlighted funds led by former members of major firms, including "Tiger Cubs" like Rahul Kishore and Jim Chanos of Kynikos Associates.

Kevin Salimian, who is about to launch Voxel Capital, has bet on Infineon Technologies, a German company specializing in semiconductors for automotive and power plants. According to Salimian, the growing demand for energy, driven by the rise of AI, could increase the company's value by 58% by the end of next year.

Betting Against DaVita: A Bold Strategy

The Sohn Conference is also known for its bold short-selling ideas. Zachary Datikash, a former collaborator of Jim Chanos, founded Third North Capital and has taken a position against DaVita, one of the leading dialysis providers in the United States. Although Datikash acknowledges the company's good management and profitability, he anticipates significant structural challenges related to GLP-1, drugs that could reduce the need for dialysis.

Datikash believes these medications could delay the need for dialysis, thereby affecting DaVita's profits, as the most profitable patients are those covered by private insurance, not Medicare.

DaVita's Response to Criticism

In response to these predictions, a spokesperson for DaVita stated that GLP-1s do not pose such a straightforward threat to dialysis providers. The company is also exploring ways to improve patient access to these innovative treatments by collaborating with various stakeholders in the healthcare sector.